These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31235043)

  • 1. KRAS Mutation for Staging Resected Non-Small Cell Lung Cancer.
    Canepa M; Patel NR; Griffith RC; Ng TT; Azzoli CG
    J Thorac Oncol; 2019 Jul; 14(7):e153-e155. PubMed ID: 31235043
    [No Abstract]   [Full Text] [Related]  

  • 2. Clonality assessment of multifocal lung adenocarcinoma by pathology evaluation and molecular analysis.
    Sun W; Feng L; Yang X; Li L; Liu Y; Lv N; Lin D
    Hum Pathol; 2018 Nov; 81():261-271. PubMed ID: 30420048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUC5AC enhances tumor heterogeneity in lung adenocarcinoma with mucin production and is associated with poor prognosis.
    Dong Y; Zhou L; Zhao D; Li K; Liu Z; Che N; Liu H
    Jpn J Clin Oncol; 2020 Jun; 50(6):701-711. PubMed ID: 32083303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of peripheral lung adenocarcinoma in brush cytology obtained by EBUS plus fluoroscopy-guided bronchoscopy.
    Sánchez-Font A; Chalela R; Martín-Ontiyuelo C; Albero-González R; Dalmases A; Longarón R; Alonso-Espinaco V; Curull V; Bellosillo B; Pijuan L
    Cancer Cytopathol; 2018 Oct; 126(10):860-871. PubMed ID: 30291816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-energy spectral CT characteristics in surgically resected lung adenocarcinoma: comparison between Kirsten rat sarcoma viral oncogene mutations and epidermal growth factor receptor mutations.
    Li M; Zhang L; Tang W; Duan JC; Jin YJ; Qi LL; Wu N
    Cancer Imaging; 2019 Nov; 19(1):77. PubMed ID: 31783917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ciliated muconodular papillary tumour of the lung mimicking mucinous adenocarcinoma: a case report and literature review.
    Cheung FMF; Guan J; Luo QG; Sihoe ADL; Shen XP
    Hong Kong Med J; 2019 Feb; 25(1):71-3. PubMed ID: 30713144
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of a highly sensitive lung cancer compact panel to detect KRAS G12D in the wash fluid from a lung tumor: A case report.
    Minami D; Takigawa N; Nakajima Y; Miyahara N; Mizumori Y; Ueda M; Nakamura S; Suzuki F; Sato Y; Morikawa K; Kanehiro A
    Thorac Cancer; 2022 Jun; 13(11):1735-1738. PubMed ID: 35545933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel TNIP2-RET fusion identified in a patient with mucinous adenocarcinoma of the lung.
    Ren P; Luo N; Qi Y; Wu Y; Jin M
    Lung Cancer; 2021 Mar; 153():179-181. PubMed ID: 33478856
    [No Abstract]   [Full Text] [Related]  

  • 9. Metachronous primary lung adenocarcinomas harboring distinct KRAS mutations.
    Hu Y; Ren S; Chen C; Liang Q; Yu F; Liu W
    Thorac Cancer; 2020 Jul; 11(7):2018-2022. PubMed ID: 32415761
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Jones GD; Caso R; Tan KS; Mastrogiacomo B; Sanchez-Vega F; Liu Y; Connolly JG; Murciano-Goroff YR; Bott MJ; Adusumilli PS; Molena D; Rocco G; Rusch VW; Sihag S; Misale S; Yaeger R; Drilon A; Arbour KC; Riely GJ; Rosen N; Lito P; Zhang H; Lyden DC; Rudin CM; Jones DR; Li BT; Isbell JM
    Clin Cancer Res; 2021 May; 27(9):2604-2612. PubMed ID: 33593884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Surgical Outcomes Between Invasive Mucinous and Non-Mucinous Lung Adenocarcinoma.
    Matsui T; Sakakura N; Koyama S; Nakanishi K; Sasaki E; Kato S; Hosoda W; Murakami Y; Kuroda H; Yatabe Y
    Ann Thorac Surg; 2021 Oct; 112(4):1118-1126. PubMed ID: 33242433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinicopathological significance of ALK rearrangements and KRAS and EGFR mutations in primary pulmonary mucinous adenocarcinoma.
    Qu Y; Che N; Zhao D; Zhang C; Su D; Zhou L; Zhang L; Wang C; Zhang H; Wei L
    Tumour Biol; 2015 Aug; 36(8):6417-24. PubMed ID: 25813151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of invasive mucinous adenocarcinoma of the lung showing stepwise progression at the primary site.
    Kawai H; Sugano M; Nakano N; Muratani M; Sakashita S; Goto Y; Noguchi M
    Lung Cancer; 2019 Oct; 136():94-97. PubMed ID: 31472337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung.
    Shim HS; Kenudson M; Zheng Z; Liebers M; Cha YJ; Hoang Ho Q; Onozato M; Phi Le L; Heist RS; Iafrate AJ
    J Thorac Oncol; 2015 Aug; 10(8):1156-62. PubMed ID: 26200269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-Generation Sequencing: A Novel Approach to Distinguish Multifocal Primary Lung Adenocarcinomas from Intrapulmonary Metastases.
    Patel SB; Kadi W; Walts AE; Marchevsky AM; Pao A; Aguiluz A; Mudalige T; Liu Z; Deng N; Lopategui J
    J Mol Diagn; 2017 Nov; 19(6):870-880. PubMed ID: 28866070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucinous adenocarcinoma with lepidic pattern and with K-RAS mutation in a newborn with antenatal diagnosis of congenital pulmonary airway malformation.
    Stephanov O; Robert Y; De Fraipont F; Piolat C; Sartelet H
    Histopathology; 2018 Feb; 72(3):530-531. PubMed ID: 28889407
    [No Abstract]   [Full Text] [Related]  

  • 17. KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.
    Hwang DH; Sholl LM; Rojas-Rudilla V; Hall DL; Shivdasani P; Garcia EP; MacConaill LE; Vivero M; Hornick JL; Kuo FC; Lindeman NI; Dong F
    J Thorac Oncol; 2016 Apr; 11(4):496-503. PubMed ID: 26829311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synchronous intrapulmonary schwannoma and primary lung cancer.
    Lococo F; Carlinfante G; Rapicetta C; Ricchetti T; Brandi L; Paci M; Carbonelli C; Sgarbi G
    Lung; 2015 Jun; 193(3):439-41. PubMed ID: 25773608
    [No Abstract]   [Full Text] [Related]  

  • 19. Frequency of EGFR and KRAS mutations in Japanese patients with lung adenocarcinoma with features of the mucinous subtype of bronchioloalveolar carcinoma.
    Hata A; Katakami N; Fujita S; Kaji R; Imai Y; Takahashi Y; Nishimura T; Tomii K; Ishihara K
    J Thorac Oncol; 2010 Aug; 5(8):1197-200. PubMed ID: 20661086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct clinicopathologic characteristics of lung mucinous adenocarcinoma with KRAS mutation.
    Ichinokawa H; Ishii G; Nagai K; Kawase A; Yoshida J; Nishimura M; Hishida T; Ogasawara N; Tsuchihara K; Ochiai A
    Hum Pathol; 2013 Dec; 44(12):2636-42. PubMed ID: 24119562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.